128940.KS
Hanmi Pharm. Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 460,500.00
−2.85%Margins
Gross margin
59.6%
EBITDA margin
22.9%
EBIT margin
16.9%
Net margin
13.1%
FCF margin
12.6%
15.5%
Return on equity
9.3%
Return on assets
15.3%
Return on invested capital
0.73x
Asset turnover
KRW 270.0B
Cash from operations
KRW 28.4K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026